The Access to Prescription Digital Therapeutics Act of 2025 aims to provide Medicare and Medicaid coverage for prescription digital therapeutics.
The Access to Prescription Digital Therapeutics Act of 2025 amends titles XVIII and XIX of the Social Security Act to include coverage of prescription digital therapeutics under Medicare and Medicaid. It mandates manufacturers of these therapeutics to submit annual reports to the Secretary detailing payment rates, volume, and user numbers. The Secretary is required to establish product-specific HCPCS codes for these therapeutics and set a payment methodology. The act also allows for civil monetary penalties for manufacturers who fail to report or misrepresent information.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.